MicroBiopharm Japan Co., Ltd. launched various products using our technology of fermentation, chemical synthesis, and function of various microorganisms.
Commercial
| Compound name | CAS | Specification | Structure |
|---|---|---|---|
 Daunorubicin Hydrochloride |
23541-50-6 | USP, JP, CP, In-house |  |
 Doxorubicin Hydrochloride |
25316-40-9 | USP, JP, EP, CP, In-house |  |
| Epirubicin Hydrochloride |
56390-09-1 | JP, EP, In-house |  |
| Pirarubicin * |
72496-41-4 | JP, In-house |  |
| Aclarubicin Hydrochloride * |
75443-99-1 | JP, In-house |  |
| Compound name | CAS | Specification | Structure |
|---|---|---|---|
 Calcitriol |
32222-06-3 | USP, In-house |  |
| Compound name | CAS | Specification | Structure |
|---|---|---|---|
| cis-5-Hydroxy-L-Pipecolinic acid |
63088-78-8 | In-house |  |
| Compound name | CAS | Specification | Structure |
|---|---|---|---|
| Rapamycin (Sirolimus) Crude |
53123-88-9 | In-house |  |
Under development
| Compound name | CAS | Structure |
|---|---|---|
| Everolimus |
159351-69-6 |  |
| Oxaunomycin |
105615-58-5 |  |
| Ansamitocin P-3 |
66584-72-3 |  |
| Maytansinol |
57103-68-1 |  |
| Mertansine (DM-1) |
139504-50-0 |  |
| 25-Hydroxy vitamin D3 |
63283-36-3 |  |
| 25-Hydroxycholesterol |
2140-46-7 |  |
| Calicheamicin γ1 |
108212-75-5 |  |
Fermentation products
Fermentation+Synthesis products
Bioconversion products
* API production and formulation
